This would better fit to be a Twitter update, but I cannot resist to cite this sentence from Gabe Rivera Techmeme inventor in an older Wired conversation:
Category: venture capital
The busy life of a stem cell (biotech) startup founder
If you ever thought of launching a biotech startup… the following blogterview is for you. Jim Hardy is a long time insighful commenter of Pimm and he shared with me his brand new experience as the founder of a biotech startup in the much hyped field of regenerative medicine. The transparency of the interview makes… Continue reading The busy life of a stem cell (biotech) startup founder
BioTech(nically), Business 2.0’s new biotech blog
Business 2.0 Blog Beta Network‘s new blog BioTech(nically) was launched written by Marie Cannizzaro who says about herself in the intro post, March 27: “Before joining Business 2.0, I wrote for Dow Jones VentureWire and Stanford Magazine. I have a degree in Human Biology with a concentration in Biotechnology and Bioethics from Stanford University.” At… Continue reading BioTech(nically), Business 2.0’s new biotech blog
Stem Cell Therapy Market, US, 2005-2016: do you believe this?
This extrapolation is from the inforich and insider Stem Cell Market Analysis Fact Sheet of the 2nd Annual Stem Cell Summit, February 12-13 at San Diego, happening now. Other important facts concerning the Stem Cell Therapy Market in the U.S.:
Valley Brats in Rolling Stone’s Tech Issue: trends in journalism (weekend off)
And now for something completely different! Sometimes life is just simply life for me without any extension. This is Life.exe. So at the weekends during the largely dead webtimes, I’ll blog about other things than stem cells, regenerative medicine, maximum life extension and biotech. This week offstory is a report, which shows the transformation of… Continue reading Valley Brats in Rolling Stone’s Tech Issue: trends in journalism (weekend off)
Maximum Life CEO David Kekich: the investment strategy of life extension
David A Kekich is a heavyweight venture capitalist and investment expert. In 1999, he founded the Maximum Life Foundation, a corporation dedicated to curing aging related diseases. His LIVES™ financial strategy will finance the research needed to profitably develop life extending technologies. Kekich, who is also a lifestyle life extensionist, and very aware of current… Continue reading Maximum Life CEO David Kekich: the investment strategy of life extension